Episode Details
Back to EpisodesUS Drug Manufacturing Onshoring and Price Reduction Strategy: Healthcare Packaging
Season 2
Episode 24
Published 8 months ago
Description
How are Trump, regulators, and pharma are taking steps to bring back U.S. drug manufacturing?
The proposed "Quid Pro Quo" partnership between the Trump administration and major pharmaceutical companies is aimed at increasing U.S. drug manufacturing. While large corporations like AstraZeneca and Pfizer have agreed to substantial investments and price reductions in exchange for tariff delays, experts caution that this onshoring will take time and may not entirely resolve the complex issue of drug pricing or supply chain fragility.
This is an AI-generated episode. Read the full featured article on Healthcare Packaging.